Migraine Clinical Trials in Austin, Texas

10 recruitingAustin, Texas

Showing 110 of 10 trials

Recruiting
Phase 3

Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine

Acute Treatment of Migraine
Pfizer600 enrolled126 locationsNCT04743141
Recruiting
Phase 3

A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine

Menstrual Migraine
Pfizer723 enrolled122 locationsNCT06641466
Recruiting
Phase 3

Randomized Study in Children and Adolescents With Migraine: Acute Treatment

Pediatric Migraine
Pfizer2,100 enrolled246 locationsNCT04649242
Recruiting
Phase 3

A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years

Chronic Migraine
AbbVie420 enrolled61 locationsNCT06810505
Recruiting
Phase 3

A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent Migraine

Migraine
Pfizer200 enrolled107 locationsNCT06616194
Recruiting
Phase 3

A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine

Episodic Migraine
AbbVie450 enrolled98 locationsNCT05711394
Recruiting
Not Applicable

Responding With Evidence and Access for Childhood Headaches

MigraineMigraine DisordersHeadache Disorders+2 more
Children's Hospital Medical Center, Cincinnati400 enrolled15 locationsNCT05889624
Recruiting
Phase 3

Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)

Migraine
AbbVie1,059 enrolled124 locationsNCT05125302
Recruiting
Phase 2

A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine

Migraine
AbbVie488 enrolled54 locationsNCT06602479
Recruiting
Phase 3

Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine

Migraine
AbbVie496 enrolled106 locationsNCT06417775